D-Index & Metrics Best Publications

Ian Ganly

Memorial Sloan Kettering Cancer Center
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 75 Citations 21,728 345 World Ranking 14456 National Ranking 7452

Overview

What is he best known for?

The fields of study Ian Ganly is best known for:

Cancer
Gene
Chemotherapy

His Thyroid investigation overlaps with other areas such as Thyroid cancer and Thyroidectomy. In his research, he undertakes multidisciplinary study on Thyroid cancer and Thyroid. His Internal medicine study frequently draws connections to other fields, such as Neck dissection. He integrates many fields, such as Cancer and Pathology, in his works. Ian Ganly applies his multidisciplinary studies on Pathology and Cancer in his research. His study deals with a combination of Oncology and Gastroenterology. Gastroenterology and Oncology are two areas of study in which he engages in interdisciplinary work. He merges Surgery with Radiation therapy in his study. In his research, Ian Ganly undertakes multidisciplinary study on Radiation therapy and Surgery.

His most cited work include:

Integrated Genomic Characterization of Papillary Thyroid Carcinoma (1966 citations)
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer (1029 citations)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers (718 citations)

What are the main themes of his work throughout his whole career to date

His study on Surgery is mostly dedicated to connecting different topics, such as Radiation therapy, Retrospective cohort study and Head and neck cancer. Ian Ganly conducts interdisciplinary study in the fields of Radiation therapy and Surgery through his research. In his study, he carries out multidisciplinary Internal medicine and Gastroenterology research. Ian Ganly undertakes interdisciplinary study in the fields of Cancer and Gene through his works. With his scientific publications, his incorporates both Gene and Cancer. In his works, he performs multidisciplinary study on Oncology and Pathology. By researching both Pathology and Oncology, Ian Ganly produces research that crosses academic boundaries. His study ties his expertise on Thyroid carcinoma together with the subject of Thyroid. His Thyroid carcinoma study frequently involves adjacent topics like Thyroid.

Ian Ganly most often published in these fields:

Internal medicine (84.68%)
Cancer (65.11%)
Surgery (55.74%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally.
Cell (2014)

1857 Citations

A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

Fadlo R. Khuri;John Nemunaitis;Ian Ganly;James Arseneau.
Nature Medicine (2000)

1389 Citations

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

Iñigo Landa;Tihana Ibrahimpasic;Laura Boucai;Rileen Sinha.
Journal of Clinical Investigation (2016)

757 Citations

Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer

J. Nemunaitis;F. Khuri;I. Ganly;J. Arseneau.
Journal of Clinical Oncology (2001)

616 Citations

A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer

Ian Ganly;Ian Ganly;David Kirn;Susan G. Eckhardt;Gail I. Rodriguez.
Clinical Cancer Research (2000)

559 Citations

Selective Replication and Oncolysis in p53 Mutant Tumors with ONYX-015, an E1B-55kD Gene-deleted Adenovirus, in Patients with Advanced Head and Neck Cancer: A Phase II Trial

John Nemunaitis;Ian Ganly;Fadlo Khuri;James Arseneau.
Cancer Research (2000)

539 Citations

The head and neck cancer immune landscape and its immunotherapeutic implications.

Rajarsi Mandal;Yasin Şenbabaoğlu;Alexis Desrichard;Jonathan J. Havel.
JCI insight (2016)

474 Citations

The Mutational Landscape of Adenoid Cystic Carcinoma

Allen S Ho;Kasthuri Kannan;David M Roy;Luc G T Morris.
Nature Genetics (2013)

397 Citations

Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease

Iñigo Landa;Ian Ganly;Timothy A. Chan;Norisato Mitsutake.
The Journal of Clinical Endocrinology and Metabolism (2013)

389 Citations

Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation

Luc G T Morris;Andrew M Kaufman;Yongxing Gong;Deepa Ramaswami.
Nature Genetics (2013)

353 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Ian Ganly